Comparison of inflammatory biomarkers in outpatients with prior myocardial infarction

International Heart Journal

Volumn 57, Issue 1, 2016, Pages 11-17

  Minamisawa, Masatoshi ^a   Motoki, Hirohiko ^a   Izawa, Atsushi ^a   Kashima, Yuichiro ^a   Hioki, Hirofumi ^a   Abe, Naoyuki ^a   Miura, Takashi ^a   Ebisawa, Soichiro ^a   Miyashita, Yusuke ^a   Koyama, Jun ^a   Ikeda, Uichi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Coronary artery disease; Growth differentiation factor 15; Prognosis

Indexed keywords

ATORVASTATIN; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; INTERLEUKIN 1 RECEPTOR; PRAVASTATIN;

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; TURBIDIMETRY; BLOOD; COMPARATIVE STUDY; COMPLICATION; METABOLISM; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR;

AGED; BIOMARKERS; C-REACTIVE PROTEIN; FEMALE; FOLLOW-UP STUDIES; GROWTH DIFFERENTIATION FACTOR 15; HUMANS; INFLAMMATION; MALE; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; OUTPATIENTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84954497260     PISSN: 13492365     EISSN: 13493299     Source Type: Journal    
DOI: 10.1536/ihj.15-197     Document Type: Article

References (32)

1. Tapanainen JM, Lindgren KS, Mäkikallio TH, Vuolteenaho O, Leppäluoto J, Huikuri HV. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2004; 43: 757- 63.
2. Foussas SG, Zairis MN, Lyras AG, et al. Early prognostic usefulness of C-reactive protein added to the Thrombolysis In Myocardial Infarction risk score in acute coronary syndromes. Am J Cardiol 2005; 96: 533-7.
3. Khan SQ, Ng K, Dhillon O, et al. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J 2009; 30: 1057-65.
4. Wang TJ, Wollert KC, Larson MG, et al. Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study. Circulation 2012; 126: 1596-604.
5. Rienstra M, Yin X, Larson MG, et al. Relation between soluble ST2, growth differentiation factor-15, and high-sensitivity troponin I and incident atrial fibrillation. Am Heart J 2014; 167: 109-15.
6. Stiermaier T, Adams V, Just M, et al. Growth differentiation factor-15 in Takotsubo cardiomyopathy: diagnostic and prognostic value. Int J Cardiol 2014; 173: 424-9.
7. Izumiya Y, Hanatani S, Kimura Y, et al. Growth differentiation factor-15 is a useful prognostic marker in patients with heart failure with preserved ejection fraction. Can J Cardiol 2014; 30: 338-44.
8. Morrow DA, Braunwald E. Future of biomarkers in acute coronary syndromes: moving toward a multimarker strategy. Circulation 2003; 108: 250-2.
9. Kruk M, Przyłuski J, Kalińczuk Ł, et al; ANIN Myocardial Infarction Registry Group. Association of non-specific inflammatory activation with early mortality in patients with ST-elevation acute coronary syndrome treated with primary angioplasty. Circ J 2008; 72: 205-11.
10. Wollert KC, Kempf T, Peter T, et al. Prognostic value of growthdifferentiation factor-15 in patients with non-ST-elevation acute coronary syndrome. Circulation 2007; 115: 962-71.
11. Wollert KC, Kempf T, Lagerqvist B, et al. Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome. Circulation 2007; 116: 1540-8.
12. Kempf T, Björklund E, Olofsson S, et al. Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. Eur Heart J 2007; 28: 2858-65.
13. Bonaca MP, Morrow DA, Braunwald E, et al. Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol 2011; 31: 203-10.
14. Sabatine MS, Morrow DA, Higgins LJ, et al. Complementary roles for biomarkers of biomechanical strain ST2 and N-terminal prohormone B-type natriuretic peptide in patients with ST-elevation myocardial infarction. Circulation 2008; 117: 1936-44.
15. Shimpo M, Morrow DA, Weinberg EO, et al. Serum levels of the interleukin-1 receptor family member ST2 predict mortality and clinical outcome in acute myocardial infarction. Circulation 2004; 109: 2186-90.
16. Damman P, Kempf T, Windhausen F, et al; ICTUS investigators. Growth-differentiation factor 15 for long-term prognostication in patients with non-ST-elevation acute coronary syndrome: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substudy. Int J Cardiol 2014; 172: 356-63.
17. Logeart D, Thabut G, Jourdain P, et al. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol 2004; 43: 635-41.
18. Kashima Y, Izawa A, Aizawa K, et al. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study. J Cardiol 2009; 54: 76-9.
19. Izawa A, Kashima Y, Miura T, et al. Assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction. Circ J 2015; 79: 161-8.
20. Thygesen K, Alpert JS, White HD, et al; Joint ESC/ACCF/AHA/ WHF Task Force for the Redefinition of Myocardial Infarction, Universal definition of myocardial infarction. Circulation 2007; 116: 2634-53.
21. Matsuo S, Imai E, Horio M, et al; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982-92.
22. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002; 347: 1557-65.
23. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350: 1387-97.
24. Kushner I, Broder ML, Karp D. Control of the acute phase response. Serum C-reactive protein kinetics after acute myocardial infarction. J Clin Invest 1978; 61: 235-42.
25. Kempf T, Eden M, Strelau J, et al. The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury. Circ Res 2006; 98: 351-60.
26. Zimmers TA, Jin X, Hsiao EC, McGrath SA, Esquela AF, Koniaris LG. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury. Shock 2005; 23: 543-8.
27. Weinberg EO, Shimpo M, De Keulenaer GW, et al. Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction. Circulation 2002; 106: 2961-6.
28. Mather AN, Fairbairn TA, Artis NJ, Greenwood JP, Plein S. Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance. Int J Cardiol 2013; 166: 458-64.
29. Lind L, Wallentin L, Kempf T, et al. Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study. Eur Heart J 2009; 30: 2346-53.
30. Kim CS, Kim MJ, Kang YU, et al; Korea Acute Myocardial Infarction Registry Investigators. Influence of renal dysfunction on clinical outcomes in patients with congestive heart failure complicating acute myocardial infarction. Int Heart J 2013; 54: 304-10.
31. Shiraishi J, Kohno Y, Nakamura T, et al; AMI-Kyoto Multi-Center Risk Study Group. Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. Int Heart J 2014; 55: 301-6.
32. Simonson MS, Tiktin M, Debanne SM, et al. The renal transcriptome of db/db mice identifies putative urinary biomarker proteins in patients with type 2 diabetes: a pilot study. Am J Physiol Renal Physiol 2012; 302: F820-9.